Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170411033365N6Phase 3Completed
Phase 3, randomised, double-blind trial in postanesthetic shivering (PAS) comparing Meperidine with Ketorolac (2 arms). Primary endpoint: Severity of shivering. Started Nov 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170411033365N6.